Font Size: a A A
Keyword [First-line Treatment]
Result: 121 - 136 | Page: 7 of 7
121. Clinical Investigation Of Anlotinib Combined With Chemotherapy As First-Line Treatment For Advanced Driver Gene Wild-Type Lung Adenocarcinoma
122. Comparative Efficacy And Safety Of PD-1/PD-L1 Inhibitors Versus Platinum-based Chemotherapy For The First-line Treatment Of Advanced Non-small Cell Lung Cancer:A Meta Analysis Of Randomized Controlled Trials
123. Pharmacoeconomic Evaluation Of Camrelizumab Plus Chemotherapy In First-line Treatment Of Advanced Non-squamous Non-small-cell Lung Cancer
124. Clinical Observation Of Carrelizumab Combined With Chemotherapy As First-Line Treatment In Advanced Non-Squamous NSCLC Negative For Driver Gene Mutations
125. The Correlation Between PP-L1 Expression And The Efficacy Of Immunocheckpoint Inhibitors In First-line Treatment Of Advanced Non-small Cell Lung Cancer:Meta-analysis
126. Comparing Doublet And Single Cytotoxic Agent Chemotherapy As First-line Treatment In Elderly Patients With Advanced Non Small-cell Lung Cancer Efficacy And Safety Analysis
127. Clinical Observation Of Recombinant Human Endostatin Combined With Chemotherapy In The First-line Treatment Of Advanced Gastric Cancer
128. Apatinib Plus Metronomic S-1 Versus S-1 Plus Oxaliplatin,or Sorafenib Alone In The First-line Treatment Of Advanced Primary Liver Cancer
129. Analysis Of The Safety And Effectiveness Of Lenvatinib Combined With PD-1 Inhibitor Compared With Sorafenib In The First-line Treatment Of Advanced Hepatocellular Carcinom
130. Efficacy And Safety Of Apatinib Mesylate Combined With Paclitaxel And S-1 In The First-line Treatment Of Patients With Peritoneal Metastasis Of Gastric Cancer
131. Clinical Observation Of Albumin-bound Paclitaxel Combined With Cisplatin In The First-line Treatment Of Advanced Esophageal Squamous Cell Carcinoma
132. Systematic Review Of The Efficacy And Safety Of Immunotherapy Combined With Chemotherapy In The First-line Treatment Of Advanced Esophageal Squamous Cell Carcinoma
133. Comparative Study On The Clinical Efficacy Of Different Taxoides Combined With Platinum Synchro Radiotherapy In The First-line Treatment Of Esophageal Cancer
134. Clinical Analysis Of Carboplatin-based Regimens As First-line Treatment Of Advanced Breast Cancer
135. First-line Treatment With Atezolizumab Plus Nab-paclitaxel For Advanced Triple-negative Breast Cancer: A Cost-utility Analysis
136. Expression Of Ki67 And ERCC1 In Metastasis And Clinical Significance In First-line Treatment Of Metastatic Nasopharyngeal Carcinoma
  <<First  <Prev  Next>  Last>>  Jump to